Go to the list of all blogs
Joma Foster's Avatar
published in Blogs
Jul 17, 2026
GE Vernova (GEV) +5.5% Gain in 30 Days: AI Data Center Demand Powers Recovery

GE Vernova (GEV) +5.5% Gain in 30 Days: AI Data Center Demand Powers Recovery

Key Takeaways

  • GE Vernova shares closed at $1,036.22 on July 16, 2026, reflecting a gain of approximately 5.5% over the trailing 30-day period, recovering from a volatile trading range that saw the stock dip below $870 in early June.
  • The company's $163 billion backlog and 71% organic order growth in Q1 2026 underscore surging demand for gas turbines, grid equipment, and electrification solutions tied to AI data center buildouts.
  • Q2 2026 earnings are scheduled for July 22, with Morgan Stanley naming GE Vernova a top pick and consensus estimates pointing to another quarter of strong order momentum.
  • Wind segment headwinds and an $11 billion capital expenditure and R&D commitment through 2028 remain key areas of investor focus alongside the broader AI-driven growth narrative.
  • Analyst consensus stands at Moderate Buy with an average price target of approximately $1,090, though some firms project targets as high as $1,424.

GE Vernova's Recent Price Action

GE Vernova shares have experienced a pronounced rebound in recent weeks after a sharp correction in late May and early June 2026 sent the stock from above $1,120 to an intra-quarter low near $867. The recovery has been fueled by sustained enthusiasm around AI-driven electricity demand, a rapidly expanding equipment backlog, and anticipation ahead of the company's July 22 earnings release. Trading near $1,036, the stock sits roughly 60% higher year-to-date, with a 50-day simple moving average of approximately $1,037 and a 200-day moving average around $908. The company's market capitalization stands at roughly $278 billion, and its beta of 1.09 indicates moderate sensitivity to broader market swings. From what I see, this setup reflects how quickly sentiment can shift when the AI power theme takes center stage.

A Closer Look at GE Vernova's Operations

GEV is a purpose-built global energy company formed from the legacy energy businesses of General Electric. Headquartered in Cambridge, Massachusetts, the company operates across three primary segments: Power, Wind, and Electrification. Its Power segment designs and services gas, steam, nuclear, and hydroelectric turbines, with an installed base of roughly 7,000 gas turbines generating recurring, high-margin services revenue. The Electrification segment covers grid solutions, power conversion, storage, and software — all critical to modernizing aging electrical infrastructure. The Wind segment provides onshore and offshore wind turbines, though it has faced persistent margin pressure. With approximately 85,000 employees in over 100 countries, GE Vernova sits at the intersection of global electrification, decarbonization, and the unprecedented power demands of artificial intelligence infrastructure. One thing that stands out is how the Power and Electrification segments position the company to benefit directly from data center expansion.

Key Recent Moves and Analyst Sentiment

Several developments have shaped GE Vernova's investment narrative over the past month. On July 16, the company inaugurated its expanded Advanced Research Center Frontier Campus in Niskayuna, New York — a more than $110 million investment expected to create 75 new research positions and accelerate innovation in direct air capture, AI-based inspection, and advanced power conversion technologies. Separately, GE Vernova secured two contracts from Stromnetz Berlin to deliver SF₆-free gas-insulated substations using its g³ technology, reinforcing its position in the European grid modernization market.

Analyst activity has been notably bullish. Morgan Stanley named GE Vernova a top pick heading into Q2 earnings, citing strong quarterly performance expectations. Bernstein initiated coverage with an Outperform rating and a $1,206 price target, while Bank of America Securities reiterated a Buy rating with a $1,310 target. Of 38 analysts covering the stock, 24 rate it Strong Buy, six rate it Buy, and eight rate it Hold. Institutional interest remains robust, with multiple 13F filings revealing increased positions from firms including Twin Capital Management, SteelPeak Wealth, and Geneos Wealth Management during the first quarter. On the other hand, insider selling by CEO Victor Abate and CAO Matthew Joseph Potvin, along with Fubon Securities initiating coverage with a Hold rating, introduce nuanced signals worth monitoring. I also checked this using Tickeron’s AI Screener to see how the stock compares to others in the industry.

2026 Outlook and What Investors Should Watch

The July 22 Q2 earnings report represents the most immediate catalyst for GE Vernova. Bank of America Securities projects total orders of approximately $19.6 billion, up 59% year-over-year, with Power orders expected at $11.1 billion and Electrification at $7 billion. Polymarket prediction markets give 85% odds of Q2 orders exceeding $18 billion. Beyond earnings, investors should monitor the trajectory of slot reservation agreements, which grew to 56 gigawatts in Q1 — a leading indicator of future equipment deliveries and long-term services revenue. The company's $11 billion capex and R&D plan through 2028, while essential for capturing AI-driven demand, introduces execution risk if large projects face delays. Wind segment profitability remains a wildcard, as does the macroeconomic backdrop affecting energy infrastructure spending. With a forward P/E near 37 and elevated expectations already priced in, any deviation from the growth narrative could trigger outsized stock reactions in either direction. This is important because the valuation leaves little room for disappointment.

Exploring Data-Driven Trading Approaches

For investors seeking data-driven approaches to navigate stocks like GE Vernova, I turn to tools that help surface patterns across thousands of tickers. Tickeron's Trending AI Robots page offers a curated view of top-performing AI trading bots. Tickeron hosts hundreds of AI-driven trading bots that actively trade thousands of tickers across various strategies, timeframes, and performance metrics. The Trending AI Robots section highlights only the most relevant and consistently strong performers, allowing users to scan bots differentiated by trading style, risk profile, and return history. Whether focusing on short-term swing trades or longer-term trend-following approaches, this curated selection provides a streamlined entry point into algorithmic trading strategies. Explore the page to see which bots are currently capturing market attention.

Disclaimer

The information on this webpage is provided for general informational and educational purposes only and is not intended as investment advice, a recommendation to purchase or sell any security, or an offer or solicitation related to investments. It does not consider your personal financial situation, goals, or risk profile, and all investing carries inherent risks, including the possibility of losing your entire investment. For more details, please review our full disclaimer.

Disclaimers and Limitations

Related Ticker: GEV

GEV in downward trend: price dove below 50-day moving average on July 22, 2026

GEV moved below its 50-day moving average on July 22, 2026 date and that indicates a change from an upward trend to a downward trend. In of 14 similar past instances, the stock price decreased further within the following month. The odds of a continued downward trend are .

Price Prediction Chart

Technical Analysis (Indicators)

Bearish Trend Analysis

The Stochastic Oscillator entered the overbought zone. Expect a price pull-back in the foreseeable future.

The Momentum Indicator moved below the 0 level on August 06, 2026. You may want to consider selling the stock, shorting the stock, or exploring put options on GEV as a result. In of 42 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are .

The Moving Average Convergence Divergence Histogram (MACD) for GEV turned negative on July 09, 2026. This could be a sign that the stock is set to turn lower in the coming weeks. Traders may want to sell the stock or buy put options. Tickeron's A.I.dvisor looked at 22 similar instances when the indicator turned negative. In of the 22 cases the stock turned lower in the days that followed. This puts the odds of success at .

The 10-day moving average for GEV crossed bearishly below the 50-day moving average on July 28, 2026. This indicates that the trend has shifted lower and could be considered a sell signal. In of 6 past instances when the 10-day crossed below the 50-day, the stock continued to move higher over the following month. The odds of a continued downward trend are .

Following a 3-day decline, the stock is projected to fall further. Considering past instances where GEV declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .

The Aroon Indicator for GEV entered a downward trend on August 06, 2026. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.

Bullish Trend Analysis

Following a 3-day Advance, the price is estimated to grow further. Considering data from situations where GEV advanced for three days, in of 161 cases, the price rose further within the following month. The odds of a continued upward trend are .

GEV may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.

Fundamental Analysis (Ratings)

The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating very strong sales and a profitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating steady price growth. GEV’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is significantly overvalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: GEV's P/B Ratio (22.272) is slightly higher than the industry average of (5.976). P/E Ratio (28.678) is within average values for comparable stocks, (77.292). Projected Growth (PEG Ratio) (1.699) is also within normal values, averaging (2.090). Dividend Yield (0.002) settles around the average of (0.018) among similar stocks. P/S Ratio (6.588) is also within normal values, averaging (140.812).

The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating that the returns do not compensate for the risks. GEV’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 73, placing this stock worse than average.

Notable companies

The most notable companies in this group are Illinois Tool Works (NYSE:ITW), Ingersoll Rand (NYSE:IR), Generac Holdings (NYSE:GNRC).

Industry description

The industry makes and maintains machines for consumers, the industry, and most other companies. While it has traditionally been categorized as heavy industry, some smaller companies are also branching into the light category. The industry is pivotal in providing the equipment for production in businesses like agriculture, mining, industry and construction, gas, electricity and water utilities. It also supplies supporting equipment for almost all sectors of the economy, such as equipment for heating, and air conditioning of buildings. Illinois Tool Works Inc., Parker-Hannifin Corporation and Rockwell Automation Inc are some of the major U.S. companies operating in this industry.

Market Cap

The average market capitalization across the Industrial Machinery Industry is 17B. The market cap for tickers in the group ranges from 1.55K to 266.41B. GEV holds the highest valuation in this group at 266.41B. The lowest valued company is XEBEF at 1.55K.

High and low price notable news

The average weekly price growth across all stocks in the Industrial Machinery Industry was 4%. For the same Industry, the average monthly price growth was 1%, and the average quarterly price growth was -0%. WFF experienced the highest price growth at 31%, while LBGJ experienced the biggest fall at -99%.

Volume

The average weekly volume growth across all stocks in the Industrial Machinery Industry was -14%. For the same stocks of the Industry, the average monthly volume growth was -5% and the average quarterly volume growth was -34%

Fundamental Analysis Ratings

The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows

Valuation Rating: 56
P/E Growth Rating: 55
Price Growth Rating: 54
SMR Rating: 72
Profit Risk Rating: 72
Seasonality Score: -33 (-100 ... +100)
View a ticker or compare two or three
GEV
Daily Signal:
Gain/Loss:
Interact to see
Advertisement
A.I.Advisor
published price charts
Last 5 trading days
A.I. Advisor
published General Information

General Information

Industry IndustrialMachinery

Profile
Details
Industry
N/A
Address
58 Charles Street
Phone
+1 617-674-7555
Employees
N/A
Web
https://www.gevernova.com
Interact to see
Advertisement
Novartis (NVS) reports Q4/FY 2025 earnings on February 4, 2026, with consensus calling for ~$1.99 EPS on ~$13.7 billion in revenue. Sanofi (SNY) delivered strong FY 2025 results on January 29, reporting €43.6 billion in sales (+9.9% CER) and 15% business EPS growth.
Novo Nordisk (NVO) reports Q4 2025 earnings on February 4, 2026, with consensus estimates of $11.96 billion in revenue and $0.89 EPS, reflecting a moderation in GLP-1 growth. Eli Lilly (LLY) is expected to report around the same time, with projections of $17.87 billion in revenue and $6.99 EPS, driven by continued volume gains from Mounjaro and Zepbound.
MUFG is expected to report Q3 FY2026 EPS of about $0.30, broadly in line with its recent pattern of earnings beats.
Banco Santander (SAN) reports Q4 2025 earnings on February 4, 2026, following record nine-month attributable profit of €10.3 billion, up 11% year over year.
Uber (UBER) reports Q4 2025 earnings on February 4, 2026, with consensus estimates of $0.78 EPS and $14.32 billion in revenue, up about 20% year over year.
Qualcomm’s Q1 FY2026 report, covering the period ended December 28, 2025, arrives amid a pivotal shift in the semiconductor landscape. While handset growth moderates, the company is expanding in automotive, IoT, and AI-enabled devices.
UBS Group AG reports Q4 2025 earnings on February 4, 2026, with consensus EPS ranging $0.25–$0.67 and revenue around $11.62 billion, down YoY. HSBC Holdings plc reports Q4 earnings on February 25, 2026, with consensus EPS ~$1.57; Q3 showed resilient net interest income despite $1.4B in legal provisions.
Boston Scientific’s Q4 caps a transformative year, driven by ~15.5% organic growth from WATCHMAN, FARAPULSE electrophysiology, and MedSurg expansions. As a leader in minimally invasive devices, BSX’s results set the benchmark against Medtronic and Stryker—diversified medtech giants navigating tariffs, procedural rebounds, and innovation.
Arm, the leading provider of energy-efficient processor designs powering over 99% of smartphones and expanding into AI data centers, faces high scrutiny in Q3 FY2026 (ending Dec 31, 2025). After a strong Q2 with record royalty and licensing revenue, investors are focused on whether AI demand will continue to drive robust growth.
CME Group (CME): Q4 2025 earnings due February 4, 2026; consensus expects adjusted EPS $2.75 and revenue ~$1.6B. S&P Global (SPGI): Q4 2025 earnings due February 10, 2026; Q3 posted EPS $4.73 and 9% revenue growth, driven by Ratings, Indices, and Market Intelligence.
Datadog (DDOG) has come under pressure in recent sessions as volatility across the software sector weighs on sentiment ahead of earnings. Trading in the $108–120 range following a pullback from highs near $200, the stock reflects a disconnect between near-term market caution and resilient underlying fundamentals.
Starbucks shares have shown renewed strength in recent trading, rebounding from earlier lows within a 52-week range of $75.50 to $117.46. The recovery reflects improving comparable sales trends and a return to transaction growth, suggesting early progress from operational initiatives aimed at reconnecting with customers.
DoorDash holds a Strong Buy consensus from 33 analysts, with an average 12-month price target of $280.82, implying more than 40% upside from recent trading levels.
Amazon’s Q4 report capped a strong year marked by accelerating cloud growth, steady retail execution, and expanding advertising profitability. The results reinforced Amazon’s positioning as a core beneficiary of enterprise AI demand, particularly through AWS, while highlighting improving operating leverage across the broader business.
ConocoPhillips reported Q4 2025 adjusted EPS of $1.02, below consensus of $1.08, driven by weaker realized commodity prices.
ICE reported Q4 2025 net revenues of $2.5 billion, up 8% year-over-year, capping 20 consecutive years of record annual revenues at $9.9 billion.
Eli Lilly’s Q4 results highlight explosive growth from GLP-1 therapies, cementing leadership in obesity and diabetes. The company’s strong revenue beat and robust 2026 guidance illustrate high-growth pharma dynamics. Johnson & Johnson, in contrast, exemplifies a diversified healthcare strategy, combining pharmaceuticals, MedTech, and consumer health for steady expansion.
Eli Lilly (LLY), AbbVie (ABBV), and Merck (MRK) all reported strong Q4 2025 earnings, but the market reacted differently to each, reflecting variations in growth profiles, product concentration, and sector dynamics. AbbVie delivered Q4 revenue of $16.62 billion, up 10% year-over-year, with full-year revenue reaching $61.2 billion, an 8.6% increase. Adjusted EPS came in at $2.71, surpassing consensus, though shares dipped following the report amid ongoing Humira concerns
Novo Nordisk (NVO) reported Q4 2025 EPS of $1.02, surpassing estimates of $0.92, with revenue of $12.53B vs $11.99B expected. Full-year 2025 sales rose 10% at constant exchange rates (CER) to DKK 309B, but 2026 guidance anticipates a 5–13% decline at CER due to pricing pressures. Novartis (NVS) posted Q4 core EPS of $2.03, beating $1.99 estimates; net sales of $13.34B slightly missed consensus. FY sales grew 8%, with core EPS up 17% to $8.98.
MUFG (Mitsubishi UFJ Financial Group) posted Q3 FY2026 profits of ¥1.81 trillion, up 3.7% YoY, on track for its full-year target of ¥2.1 trillion. HSBC is set to report Q4 FY2025 earnings on Feb 25, 2026, with consensus EPS around $1.60; recent quarters showed resilient net interest income (NII) supported by Asia wealth growth.